Filgrastim is typically administered as an injection by a healthcare provider, but in some cases, patients can be trained to administer the injection at home. Here’s a step-by-step guide on how it is generally used:

Instructions for Use:

1. Follow your doctor’s instructions carefully. Filgrastim should be injected as directed by your healthcare provider.
   
   
2. Injection sites: Filgrastim is often injected under the skin (subcutaneous injection) into the fatty tissue, usually around the abdomen, thigh, or upper arm.
   
   
3. Injection schedule: The typical dosage is given once daily, but your healthcare provider will let you know the exact schedule based on your medical needs.
   
   
4. Preparation: If you are administering the injection at home, follow proper sterile techniques. Wash your hands thoroughly and use clean equipment. If the medication is in a vial, make sure to mix it properly before injecting.
   
   
5. Storing filgrastim: Filgrastim should be stored in the refrigerator. Don’t freeze it, and make sure to bring it to room temperature before injecting.
   
   

If you miss a dose, contact your healthcare provider to get advice on what to do next. Do not attempt to inject more than prescribed to make up for a missed dose.

Filgrastim works by stimulating the bone marrow to produce more neutrophils—a type of white blood cell essential for fighting infections. Neutrophils are among the first cells to respond to infection in the body, and having a higher count of these cells helps prevent serious infections, especially in people who have weakened immune systems due to conditions like cancer or undergoing treatments like chemotherapy.

Here’s how filgrastim works in the body:

1. Stimulating bone marrow: Filgrastim directly stimulates the bone marrow, which is the part of the body that produces blood cells, to increase the production of neutrophils.
   
   
2. Increased white blood cell count: As more neutrophils are produced, the body has a better defense against infections.
   
   

Faster recovery after chemotherapy: Chemotherapy can damage the bone marrow, resulting in a drop in white blood cells. Filgrastim helps speed up the recovery of white blood cell production after chemotherapy.

While filgrastim is generally well-tolerated, like all medications, it can cause side effects. Most side effects are mild, but it’s important to be aware of any possible adverse reactions.

Common Side Effects:

• Bone pain: One of the most common side effects of filgrastim is bone pain, as the medication stimulates the bone marrow.
  
  
• Injection site reactions: Redness, pain, or swelling at the injection site is also common.
  
  
• Fatigue: Some patients feel tired or fatigued during treatment.
  
  
• Headache: Headaches may occur during treatment.
  
  

Serious Side Effects:

• Allergic reactions: Rarely, some people may experience an allergic reaction to filgrastim, which could include symptoms such as swelling, difficulty breathing, or rash.
  
  
• Spleen problems: Filgrastim can, in rare cases, cause the spleen to enlarge or even rupture, which may cause pain in the left side of the abdomen.
  
  
• Severe bone pain: Although bone pain is a common side effect, in some cases, it may become severe or persistent. If this occurs, inform your doctor.
  
  

If you experience any severe symptoms like trouble breathing, dizziness, or sharp pain in the abdomen, contact your healthcare provider immediately.

Before using filgrastim, there are several precautions to consider:

Use with Caution If:

• You have a history of spleen problems, such as an enlarged spleen or spleen rupture.
  
  
• You are allergic to filgrastim or any of its ingredients.
  
  
• You have any heart conditions, as filgrastim can sometimes cause increased levels of white blood cells and lead to heart-related side effects.
  
  

Do Not Use If:

• You have a known allergy to filgrastim or any component of the medication.
  
  
• You have been diagnosed with sickle cell anemia (a genetic blood disorder), as filgrastim may cause problems in people with this condition.
  
  

It’s essential to have regular blood tests during treatment to monitor the effects of filgrastim, especially regarding white blood cell count and potential side effects.

Filgrastim may interact with certain medications, so it’s important to inform your doctor about any other medications you are taking, including prescription drugs, over-the-counter medications, and herbal supplements.

1. Chemotherapy drugs: Certain chemotherapy drugs that affect bone marrow function may interact with filgrastim, either increasing or decreasing its effectiveness.
   
   
2. Lithium: This medication, used for mood disorders, may increase the number of white blood cells in the body. When taken with filgrastim, it may cause an excessive increase in white blood cell count, so it’s important to monitor levels closely.
   
   
3. Other immune-modulating drugs: If you are using other medications that influence your immune system, it may change how your body responds to filgrastim, and your doctor may adjust your treatment accordingly.
   
   

The dosage of filgrastim depends on the individual’s medical condition, weight, and response to treatment. The usual starting dose is 5 mcg per kilogram of body weight, given once daily via subcutaneous injection or intravenously.

For patients with bone marrow transplant, the dose is typically 10 mcg per kilogram of body weight. Your healthcare provider will adjust the dose based on your response to treatment, using blood tests to monitor your white blood cell count.

Filgrastim is a prescription-only medication, and it is typically prescribed for patients who are at risk of infections due to chemotherapy, bone marrow transplants, or certain blood disorders. A healthcare provider will determine if filgrastim is right for you based on your medical history and specific needs.

It is important to follow your doctor’s instructions carefully, including dosage and injection schedule. Regular monitoring of your white blood cell count will also help ensure the medication is working effectively.

• What is Filgrastim used for?
  It is used to stimulate white blood cell (neutrophil) production in people whose counts are low due to:

  • Chemotherapy-induced neutropenia (low WBCs from cancer treatment)

  • Bone marrow or stem cell transplantation

  • Severe chronic neutropenia (genetic or idiopathic)

  • Peripheral blood stem cell (PBSC) mobilization before transplant

  • Certain HIV/AIDS treatments that cause low neutrophils

• What are the brand names?

  • Neupogen® (original brand)

  • Zarxio®, Nivestym®, and Releuko® — FDA-approved biosimilars

• What is the active ingredient?
  Filgrastim, a recombinant human granulocyte colony-stimulating factor (G-CSF).

• How does Filgrastim work?

  • It acts on the bone marrow to increase production of neutrophils, a type of white blood cell crucial for fighting infection.

  • Helps shorten the duration of neutropenia and reduce the risk of infection after chemotherapy or bone marrow suppression.

• What type of medication is it?
  A hematopoietic growth factor (specifically, a recombinant G-CSF).

• How is Filgrastim administered?

  • Injection under the skin (subcutaneous) or intravenous (IV).

  • Typically given once daily, starting 24 hours after chemotherapy and continued until white blood cells recover.

  • Administration can be done in a clinic or at home (self-injection with training).

• What are the available forms and strengths?

  • Single-use vials or prefilled syringes:

    • 300 mcg/0.5 mL

    • 480 mcg/0.8 mL

• How long does Filgrastim take to work?

  • Neutrophil counts begin to rise within 1–2 days of treatment.

  • The full effect is seen in 5–7 days.

• What are the common side effects?

  • Bone pain (most common)

  • Fatigue or headache

  • Mild fever

  • Redness, pain, or swelling at injection site

  • Nausea

• Are there serious side effects?
  Rare, but possible:

  • Splenic rupture (pain in left upper abdomen or shoulder tip)

  • Adult Respiratory Distress Syndrome (ARDS)

  • Allergic reactions (rash, swelling, breathing difficulty)

  • Sickle cell crisis (in patients with sickle cell disease)

  • Aortitis (inflammation of the aorta — rare, reversible)

• Who should not take Filgrastim?

  • People allergic to filgrastim or E. coli–derived proteins (used in its manufacture).

  • Patients with myeloid cancers (e.g., AML) should use only under specialist supervision — it may stimulate malignant cells.

• Can Filgrastim cause bone pain?
  Yes — it’s the most common side effect.
  Pain is typically mild and can be relieved with acetaminophen (Tylenol) or non-NSAID options (if approved by your doctor).

• Can it increase the risk of cancer growth?
  No — it doesn’t cause cancer, but in myeloid malignancies, it may stimulate existing abnormal cells; hence, use is monitored closely.

• Can Filgrastim be used during pregnancy?
  Only if clearly needed — animal studies show no harm, but limited human data are available.

• Can it be used while breastfeeding?
  Use with caution — it’s not known if it passes into breast milk, though systemic absorption by infants is unlikely.

• Does Filgrastim interact with other medications?

  • Minimal known interactions.

  • Should not be given concurrently with chemotherapy or radiation — start 24 hours after chemotherapy ends.

• How long is treatment continued?

  • Duration varies by indication:

    • After chemotherapy: until neutrophil count normalizes

    • Before stem cell transplant: until enough stem cells are collected

    • Chronic neutropenia: long-term, as directed by a specialist

• How should Filgrastim be stored?

  • Keep refrigerated at 2°C–8°C (36°F–46°F).

  • Do not freeze or shake.

  • If removed from the refrigerator, it can remain at room temperature for up to 24 hours before use.

• Is there a generic version available?
  Yes — several biosimilars are available:

  • Zarxio® (by Sandoz)

  • Nivestym® (by Pfizer)

  • Releuko® (by Amneal)

• Where can I get Filgrastim?
  Available by prescription only, administered in hospitals, clinics, or at home under professional guidance.